CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income (loss)	$ 15,729	$ (47,220)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	6,413	7,341
Amortization and write-off of deferred loan costs	1,816	3,450
Amortization and write-off of debt discount		7,794
Fair value adjustment of stock warrants	(1,321)	558
Deferred income taxes	361	875
Bad debt expense	(364)	866
Net non-cash income from discontinued operations		(195)
Stock compensation expense	3,910	3,285
Net gain on sale of assets	(119)	(167)
Changes in assets and liabilities:
Receivables	(21,651)	(47,510)
Inventories	(6,595)	(16,292)
Other current assets	(4,382)	(2,028)
Other assets and liabilities	(490)	(973)
Accounts payable	16,185	11,470
Accrued liabilities	21,004	22,574
Net cash provided by (used in) operating activities	30,496	(56,172)
Cash flows from investing activities:
Purchases of property, plant and equipment	(14,522)	(9,392)
Proceeds from sale of property, plant and equipment	120	1,674
Cash used for acquisitions, net	(33,165)
Decrease in restricted cash		13,030
Net cash provided by (used in) investing activities	(47,567)	5,312
Cash flows from financing activities:
Borrowings under revolving credit facility	30,000	30,000
Payments under revolving credit facility		(30,000)
Proceeds from issuance of long term debt		350,000
Payments of long-term debt and other loans	(50)	(364,763)
Deferred loan costs	(34)	(15,539)
Payment of recapitalization costs		(37)
Exercise of stock options	1,535	1,159
Repurchase of common stock	(1,306)	(1,036)
Net cash provided by (used in) financing activities	30,145	(30,216)
Net change in cash and cash equivalents	13,074	(81,076)
Cash and cash equivalents at beginning of period	54,696	131,432
Cash and cash equivalents at end of period	$ 67,770	$ 50,356